A biodegradable ocular implant for long-term suppression of intraocular pressure

Timolol maleate (TM) has been used for many years for the reduction of intraocular pressure (IOP) in glaucoma patients. However, the topical mode of administration (eyedrops) is far from optimal because of the issues of low bioavailability, high drug wastage, and lack of patient compliance. Suboptim...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Xu Wen, Liu, Kerh Lin, Veluchamy, Amutha Barathi, Lwin, Nyein Chan, Wong, Tina T., Venkatraman, Subbu S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551556/
https://www.ncbi.nlm.nih.gov/pubmed/26100093
http://dx.doi.org/10.1007/s13346-015-0240-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551556/
https://www.ncbi.nlm.nih.gov/pubmed/26100093
http://dx.doi.org/10.1007/s13346-015-0240-4

Ejemplares similares